Christine Chevreau
Impact in
- Pulmonary and Respiratory Medicine top 0.05%
- Renal cell carcinoma treatment
- Sarcoma Diagnosis and Treatment
- Oncology top 0.2%
- Vascular Tumors and Angiosarcomas
- Cancer Immunotherapy and Biomarkers
Papers in
-
- Sarcoma Diagnosis and Treatment 77
- Renal cell carcinoma treatment 52
- Oncology 65
- Vascular Tumors and Angiosarcomas 19
- Co-authors
- Bernard J. Escudier (37 shared papers)Sylvie Négrier (26 shared papers)Cezary A. Szczylik (6 shared papers)Frédéric Rolland (25 shared papers)Alain Ravaud (28 shared papers)Stéphane Marie. Oudard (22 shared papers)Ronald M. Bukowski (3 shared papers)Martin Eric Gore (3 shared papers)
- Journals
- Annals of Oncology (42 papers)European Journal of Cancer (24 papers)Journal of Clinical Oncology (15 papers)Cancer (14 papers)The Lancet Oncology (13 papers)
- Partner nations
- FranceUnited StatesLuxembourg
In The Last Decade
Christine Chevreau
264 papers receiving 21.3k citations
Christine Chevreau's Hit Papers
Peers
Comparison fields: 5 of 136
- Pulmonary and Respiratory Medicine 11.8k
- Oncology 6.4k
- Cancer Research 3.2k
- Gastroenterology 553
- Pathology and Forensic Medicine 1.8k
Countries citing papers authored by Christine Chevreau
This map shows the geographic impact of Christine Chevreau's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christine Chevreau with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christine Chevreau more than expected).
Fields of papers citing papers by Christine Chevreau
This network shows the impact of papers produced by Christine Chevreau. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christine Chevreau. The network helps show where Christine Chevreau may publish in the future.
Co-authors
The 25 scholars most cited alongside Christine Chevreau, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 274 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Sorafenib in Advanced Clear-Cell Renal-Cell Carcinoma Hit paper breakdown → | 2007 | 4078 |
| 2 | Bevacizumab plus interferon alfa-2a for treatment of metastatic renal cell carcinoma: a randomised, double-blind phase III trial Hit paper breakdown → | 2007 | 1845 |
| 3 | Sorafenib for Treatment of Renal Cell Carcinoma: Final Efficacy and Safety Results of the Phase III Treatment Approaches in Renal Cancer Global Evaluation Trial Hit paper breakdown → | 2009 | 934 |
| 4 | Recombinant Human Interleukin-2, Recombinant Human Interferon Alfa-2a, or Both in Metastatic Renal-Cell Carcinoma Hit paper breakdown → | 1998 | 783 |
| 5 | Sunitinib Alone or after Nephrectomy in Metastatic Renal-Cell Carcinoma Hit paper breakdown → | 2018 | 676 |
| 6 | Prognostic Scoring System for Primary CNS Lymphomas: The International Extranodal Lymphoma Study Group Experience Hit paper breakdown → | 2003 | 661 |
| 7 | Adjuvant Pembrolizumab after Nephrectomy in Renal-Cell Carcinoma Hit paper breakdown → | 2021 | 547 |
| 8 | 2008 | 533 | |
| 9 | Durvalumab alone and durvalumab plus tremelimumab versus chemotherapy in previously untreated patients with unresectable, locally advanced or metastatic urothelial carcinoma (DANUBE): a randomised, open-label, multicentre, phase 3 trial Hit paper breakdown → | 2020 | 400 |
| 10 | Randomized Phase III Study Comparing Paclitaxel/Cisplatin/ Gemcitabine and Gemcitabine/Cisplatin in Patients With Locally Advanced or Metastatic Urothelial Cancer Without Prior Systemic Therapy: EORTC Intergroup Study 30987 Hit paper breakdown → | 2012 | 364 |
| 11 | 2002 | 298 | |
| 12 | 2017 | 274 | |
| 13 | 1998 | 268 | |
| 14 | 1995 | 267 | |
| 15 | 2018 | 262 | |
| 16 | 2019 | 249 | |
| 17 | 2020 | 249 | |
| 18 | 2020 | 247 | |
| 19 | 2016 | 239 | |
| 20 | 2010 | 232 |
About Christine Chevreau
Christine Chevreau is a scholar working on Pulmonary and Respiratory Medicine, Oncology, Surgery, Pathology and Forensic Medicine and Rheumatology, having authored 274 papers that have together received 21.9k indexed citations. Recurring topics across this work include Sarcoma Diagnosis and Treatment (77 papers), Renal cell carcinoma treatment (52 papers), Testicular diseases and treatments (31 papers), Vascular Tumors and Angiosarcomas (19 papers), Bladder and Urothelial Cancer Treatments (16 papers), Soft tissue tumor case studies (11 papers), Chemotherapy-induced organ toxicity mitigation (11 papers) and Cardiac tumors and thrombi (10 papers). The work is most often cited by research in Pulmonary and Respiratory Medicine (11.8k citations), Oncology (6.4k citations), Cancer Research (3.2k citations), Gastroenterology (553 citations) and Pathology and Forensic Medicine (1.8k citations). Christine Chevreau has collaborated with scholars based in France, United States and Luxembourg. Frequent co-authors include Bernard J. Escudier, Sylvie Négrier, Cezary A. Szczylik, Frédéric Rolland, Alain Ravaud, Stéphane Marie. Oudard, Ronald M. Bukowski, Martin Eric Gore, Tim G Eisen and Tomasz Demkow. Their work appears in journals such as Annals of Oncology, European Journal of Cancer, Journal of Clinical Oncology, Cancer and The Lancet Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.